Study on OsseoSpeed™ TX Narrow Implants in the Upper Jaw in a Chinese Population

Partially Edentulous Jaw Clinical Trial

Official title:

An Open, Prospective, Multi-center Study to Evaluate OsseoSpeed™ TX Single Implant 3 mm Diameter in the Anterior Maxilla. A 3-years Follow-up Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01389258
• Other study ID #: CHN-0006
• Status: Completed
• Phase: N/A
• Start date: June 2011
• Est. completion date: August 2016

Study information

• Verified date: October 2019
• Source: Dentsply Sirona Implants
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX 3mm diameter implant in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior maxilla up to 3 years after loading. Hypothesis: Early loading of the 3 mm implant is a safe and predictable procedure.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 45
• Est. completion date: August 2016
• Est. primary completion date: August 2014
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 75 Years

Eligibility

Inclusion criteria:

1. Provision of informed consent

2. Aged 20-75 years at enrollment

3. History of edentulism in the study area of at least two months

4. Neighboring tooth/teeth to the planned crown(s) must have natural root(s)

5. Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned crowns

6. Deemed by the investigator to have a bone height and width suitable for 3.0 mm diameter study implant

7. Deemed by the investigator as likely to present an initially stable implant situation

Exclusion Criteria:

1. Unlikely to be able to comply with study procedures, as judged by the investigator

2. Uncontrolled pathologic processes in the oral cavity

3. Known or suspected current malignancy

4. History of radiation therapy in the head and neck region

5. History of chemotherapy within 5 years prior to surgery

6. Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration, as deemed by the investigator

7. Uncontrolled diabetes mellitus

8. Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration

9. Smoking more than 10 cigarettes per day

10. Present alcohol and/or drug abuse

11. Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)

12. Previous enrollment in the present study

13. Simultaneous participation in another clinical study, or participation in a clinical study during the last weeks prior to enrollment

Related Conditions & MeSH terms

• Jaw, Edentulous
• Partially Edentulous Jaw

Intervention

Device:
• OsseoSpeed™ TX
OsseoSpeed™ TX narrow implants (diameter 3 mm) of lengths 11-15 mm

Locations

Country	Name	City	State
China	Tong Ji University, Oral Implants Department	Shanghai
China	School of Stomatology Wuhan University	Wuhan
China	Dept. of Oral Implants, School of Stomatology, Fourth Military Medical University	Xi'an

Sponsors (1)

Lead Sponsor	Collaborator
Dentsply Sirona Implants

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Implant Survival	Implant survival rate evaluated clinically and radiographically.	Measured at the 3-year follow-up visit after implant loading.
Secondary	Implant Stability	Implant stability evaluated clinically/manually (recorded as stable yes/no).	Measured at the 3-year follow-up visit after implant loading.
Secondary	Marginal Bone Level Alteration	Marginal Bone Level (mm) determined from radiographs and expressed as a difference from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant.; Marginal Bone Level expressed in millimeters obtained at the 3-year follow-up visit compared to values obtained at delivery of the temporary restoration i.e. loading (baseline).	Measured at the 3-year follow-up visit after implant loading.
Secondary	Condition of the Periimplant Mucosa by Assessment of Probing Pocket Depth (PPD).	Change in pocket depth expressed in millimeters at time of the 3 years follow-up visit, compared to values obtained at delivery of permanent restoration, i.e. loading (baseline).; Negative value = increased pocket depth.	Measured at implant loading and at the 3-year follow-up visit after loading.
Secondary	Condition of the Periimplant Mucosa by Assessment of Bleeding on Probing (BoP).	Condition of the periimplant mucosa by assessment of Bleeding on Probing (BoP). Presented as % of implants that show presence of bleeding on probing at time of the 3-year follow-up visit.	Measured at implant loading and at the 3-year follow-up visit after loading.
Secondary	Presence of Plaque	Occurence of plaque around the study implant. Presented as proportion of implants that show presence of plaque at time of the 3-year follow-up visit.	Measured at the 3-year follow-up visit after implant loading.
Secondary	Gingival Zenith Score	Gingival zenith score measured from the gingival zenith to the incisal edge of the prosthetic crown with a periodontal probe to nearest 0.5 mm.; Presented as change from loading of permanent restoration to time of the 3-year follow-up visit.	Measured at implant loading and at the 3-year follow-up visit after loading.